title: Excluding pulmonary embolism without imaging tests--can our diagnostic algorithm be optimized?
authors.forename: Mathilde
authors.initials: M
authors.lastname: Nijkeuter
authors.forename: Lidwine W
authors.initials: LW
authors.lastname: Tick
authors.forename: Maaike
authors.initials: M
authors.lastname: Sohne
authors.forename: Marieke J H A
authors.initials: MJ
authors.lastname: Kruip
authors.forename: Harry R
authors.initials: HR
authors.lastname: Buller
authors.forename: Frank W G
authors.initials: FW
authors.lastname: Leebeek
authors.forename: Mark H H
authors.initials: MH
authors.lastname: Kramer
authors.forename: Frederikus A
authors.initials: FA
authors.lastname: Klok
authors.forename: Martin H
authors.initials: MH
authors.lastname: Prins
authors.forename: Menno V
authors.initials: MV
authors.lastname: Huisman
mesh_terms: D000465:Algorithms; D015415:Biomarkers / Q000097:blood; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D006801:Humans; D009426:Netherlands; D011237:Predictive Value of Tests; D011655:Pulmonary Embolism / Q000097:blood / Q000175:diagnosis* / Q000000981:diagnostic imaging; D012189:Retrospective Studies; D012680:Sensitivity and Specificity; D013997:Time Factors; D036542:Tomography, Spiral Computed
chemical_list: D015415:Biomarkers; D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D